compounded semaglutide deadline FDA Warns Against for Diabetes, Weight Loss FDA sets tirzepatide compounding deadlines

Regulatory Status: Its use is not yet approved by major health authorities, and legal status may vary

FDA-approved products containing semaglutide and tirzepatide are available

The overarching concern for all gastroenterologists is delaying care and canceling procedures unnecessarily because of these recommendations, Jennifer Phan, MD, medical director at Hoag Advanced Endoscopy Center in Irvine, California, and director of bariatric endoscopy at Hoag Digestive Health Institute, told Healio Gastroenterology

Retatrutide represents a significant advancement in pharmacological intervention for metabolic disorders

Results showed a significant reduction of body mass index, fasting blood sugar, and fasting serum insulin levels in the group taking CrP